Searched for
EXCIPIENT MANUFACTURER
Small pharma companies seek price caps on inputs as costs surgeIndian pharmaceutical units face a severe crisis. Input costs have surged by 200-300 percent. This is due to global conflicts disrupting ra...
Will Sudeep Pharma’s IPO stand out as a long-term growth opportunity?Sudeep Pharma plans to raise ₹95 crore for capex and expand manufacturing capacity by 50,000 tonnes by March 2026. Despite strong export re...
Drug regulatory body steps up heat on state units amid cough syrup lapsesIndia's drug regulator has directed state authorities to enforce strict testing of all raw materials used in medicines. This action follows...
Patel Chem Specialities IPO to list today: GMP hints at solid debutPatel Chem Specialities' SME IPO is set for a strong debut on August 1, fueled by overwhelming investor demand. The IPO, oversubscribed by ...
Ashish Kacholia invested in this SME IPO that has 42% GMP. Check all detailsAhmedabad-based Patel Chem Specialities launched its Rs 58.80 crore IPO today, priced at Rs 82–84 per share. The IPO, entirely a fresh issu...
Patel Chem Specialities IPO to open on July 25, price band set at Rs 82 to Rs 84 per equity sharePatel Chem Specialities' ₹58.8 crore IPO opens on July 25 and closes on July 29. Proceeds will fund a new plant, corporate needs, and expan...
Govt may mandate QR codes on vaccines, key drugs to curb counterfeitsThe government is considering mandating bar codes or QR codes on labels for vaccines, antimicrobials, narcotics, psychotropic substances, a...
ET Impact: DCGI asks pharma cos to adhere to production quality standardsThe DCGI's move comes a few days after ET reported that industrial excipients are used in manufacturing medicines and over 50 companies man...
Widespread use of industrial-grade excipients unearthed in Indian pharmaceutical manufacturingIndia's drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has discovered the widespread use of industrial-grade exci...
Maharashtra recalls Maiden Pharmaceuticals products, to inspect units making liquid oralsThe state regulator has ordered a complete examination of the manufacturing processes and the excipients or solvents that are used in cough...
Sigachi Industries IPO subscribed 71.3 times on last day of biddingMarwadi Shares and Finance said that considering the FY-21 adjusted EPS of Rs.10.80 on the post-issue basis, the company is going to list a...
Sigachi Industries IPO subscribed 23.1 times on Day 2Marwadi Shares and Finance said considering the FY-21 adjusted EPS of Rs 10.80 on a post-issue basis, the company is going to list at a P/E...
Sigachi Industries IPO sails through on Day 1, subscribed 9.5 timesDespite not being the talk of the town, analysts covering the issue are bullish on the company, giving it a thumbs up.
Sigachi Industries IPO opens: Can the least talked about issue spring a surprise?The smallest IPO in this group has not been the talk of the town, though analysts covering the issue are bullish on the company.
As input costs soar, small drug units reach out to Centre for helpThe prices of active pharmaceutical ingredients (APIs), excipients, glass vials and packaging material, among other inputs, have escalated ...
Croda strikes deal with Pfizer to supply COVID-19 vaccine additivesThe contract with Pfizer runs for five years and awards Croda an initial supply contract for four component excipients used in the producti...
Sigachi Industries files draft papers with Sebi for Rs 60 crore IPOThe issue would comprise of fresh issuance of up to 28,41,500 equity shares of face value of Rs 10 each.